EcoDrugPlus

Ensembl ID : ENSSPAG00000015321
Gene Symbol: -
Cross references: -
235 Possible Orthologues:

Ensembl ID : ENSSPAG00000014324
Gene Symbol: -
Cross references: -
235 Possible Orthologues:

Ensembl ID : ENSSPAG00000013940
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSSPAG00000005319
Gene Symbol: -
Cross references: -
154 Possible Orthologues:

Ensembl ID : ENSSPAG00000012659
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSSPAG00000012641
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSSPAG00000008715
Gene Symbol: -
Cross references: -
84 Possible Orthologues:

Ensembl ID : ENSSPAG00000010955
Gene Symbol: -
Cross references: -
120 Possible Orthologues:

Ensembl ID : ENSSPAG00000012965
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSSPAG00000008588
Gene Symbol: -
Cross references: -
236 Possible Orthologues:

Ensembl ID : ENSSPAG00000018864
Gene Symbol: -
Cross references: -
371 Possible Orthologues:

Ensembl ID : ENSSPAG00000018194
Gene Symbol: -
Cross references: -
168 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).